Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alphapharm Pty. Ltd.

Division of Mylan NV
www.alphapharm.com.au

Latest From Alphapharm Pty. Ltd.

Australian Advisors Will Ponder Sandoz’ Pegfilgrastim And Pfizer’s Trastuzumab

A body that advises Australia’s Department of Health on reimbursement will in November consider listing applications for Sandoz’ Ziextenzo pegfilgrastim candidate and well as for Pfizer’s recently authorized Trazimera trastuzumab brand.

Australia Biosimilars

Orange Book Policing May Increase, US FDA's Gottlieb Says

Commissioner says agency will modernize drug patent reference manual this year and consider potential changes to Orange Book administration policy. However, any transformative moves could trigger a court challenge.
Generic Drugs Legal Issues

Australian Pharmaceutical Industry Says Export, Sales Figures Mask Trouble On The Horizon

Australia’s pharmaceutical industry says it faces hard times, despite a recent report highlighting sales and exports. But challenges are expanding for many companies that face patent expirations, paving the way for generic manufacturers to drive prices down.

BioPharmaceutical Medical Device

Australian Pharma Industry “Astonished” By Call To Cut Patent-Term Extensions

A government draft report stuns the industry by calling for restrictions on patent-term extensions as a battle heats up on how to control costs under Australia’s Pharmaceutical Benefits Scheme.

BioPharmaceutical Australia
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Alphapharm Pharmaceuticals Pty. Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • Mylan NV
  • Senior Management
  • Martin Cross, Managing Dir.
    Stephen Fraser, Head, Fin. & Bus. Dev.
    Craig Boyd, Head, Sales
  • Contact Info
  • Alphapharm Pty. Ltd.
    Phone: (61) 2 9298 3999
    Level 1, 30 The Bond, 30-34 Hickson Rd.
    Millers Point, NSW 2000
    Australia
Advertisement
Advertisement
UsernamePublicRestriction

Register